Literature DB >> 336452

Gastrointestinal and systemic toxicity of fecal extracts from hamsters with clindamycin-induced colitis.

G D Rifkin, J Silva, R Fekety.   

Abstract

The production of toxic substances by intestinal bacteria is one pathogenic mechanism proposed for antibiotic-associated colitis. We demonstrated the presence of a toxic substance(s) in the feces of hamsters developing clindamycin-induced enterocolitis. Suspensions derived from cecal contents of clindamycin-treated animals induced a hemorrhagic ileocecitis and death within 2 to 4 days after being given orogastrically to hamsters. Intraperitoneal injection of sterile filtrates of these suspensions produced an exudative peritonitis, intraabdominal hemorrhages, and death of 80 to 100% of hamsters within 1 day. These effects were not seen with intraperitoneal injection of clindamycin or endotoxin, only small amounts of which were present in the filtrate. Incubation of the filtrate in vitro with polyvalent clostridial antitoxin neuralized its toxicity. In vitro incubation of the filtrate with normal equine serum did not reduce its in vivo toxicity. The toxic substance(s) contained in the filtrate was heat-labile and produced morphological changes in Y-1 adrenal cell cultures characteristic of heat-labile enterotoxins. Cecal filtrates obtained from saline-treated animals produced none of these effects. These preliminary studies suggest that enterotoxin-like substances, possibly produced by clostridia, may play an important role in the pathogenesis of clindamycin-induced colitis in the hamster.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 336452

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  14 in total

Review 1.  Clostridium difficile: its disease and toxins.

Authors:  D M Lyerly; H C Krivan; T D Wilkins
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

2.  Pseudomembranous colitis associated with changes in an ileal conduit.

Authors:  J R Shortland; R C Spencer; J L Williams
Journal:  J Clin Pathol       Date:  1983-10       Impact factor: 3.411

3.  Biological activities of toxins A and B of Clostridium difficile.

Authors:  D M Lyerly; D E Lockwood; S H Richardson; T D Wilkins
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

4.  Antimicrobial agent-associated colitis and diarrhea.

Authors:  W L George
Journal:  West J Med       Date:  1980-08

Review 5.  Models for the study of Clostridium difficile infection.

Authors:  Emma L Best; Jane Freeman; Mark H Wilcox
Journal:  Gut Microbes       Date:  2012-03-01

6.  Evaluation of eight cephalosporins in hamster colitis model.

Authors:  J R Ebright; R Fekety; J Silva; K H Wilson
Journal:  Antimicrob Agents Chemother       Date:  1981-06       Impact factor: 5.191

7.  Light and electron microscopic studies of antibiotic associated colitis in the hamster.

Authors:  C D Humphrey; W B Lushbaugh; C W Condon; J C Pittman; F E Pittman
Journal:  Gut       Date:  1979-01       Impact factor: 23.059

Review 8.  Clostridium difficile: clinical disease and diagnosis.

Authors:  F C Knoop; M Owens; I C Crocker
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

9.  Clindamycin-associated enterocolitis in guinea pigs: evidence for a bacterial toxin.

Authors:  F C Knoop
Journal:  Infect Immun       Date:  1979-01       Impact factor: 3.441

10.  Cecal toxin(s) from guinea pigs with clindamycin-associated colitis, neutralized by Clostridium sordellii antitoxin.

Authors:  J E Rehg
Journal:  Infect Immun       Date:  1980-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.